August 6, 2024 Cancer 0 Comments Should we extrapolate survival using ‘cure’ models? – Healthcare Economist Clinical trials are short, but the benefits of many drugs lasts months or even years beyond the duration of these trials. To quantify the ... Read More
April 23, 2024 CER 0 Comments Do patients value improvements in progression-free survival? – Healthcare Economist Progression-free survival (PFS) is a surrogate endpoint is defined as follows (by ChatGPT): In essence, PFS refers to the length of time during a ... Read More